EYPT - EyePoint Pharmaceuticals GAAP EPS of -$0.56 beats by $0.13 revenue of $7.68M beats by $0.11M
2023-05-03 07:10:13 ET
- EyePoint Pharmaceuticals press release ( NASDAQ: EYPT ): Q1 GAAP EPS of -$0.56 beats by $0.13 .
- Revenue of $7.68M (-17.4% Y/Y) beats by $0.11M .
- The company expects the cash, cash equivalents and investments on hand at March 31, 2023 and expected net cash inflows from product sales will enable it to fund current and planned operations into the second half of 2024.
For further details see:
EyePoint Pharmaceuticals GAAP EPS of -$0.56 beats by $0.13, revenue of $7.68M beats by $0.11M